Inhibitory effect of activated protein C on cerebral vasospasm after subarachnoid hemorrhage in the rabbit

Journal of Cardiovascular Pharmacology

Volumn 39, Issue 5, 2002, Pages 729-738

  Mizuno, Yusuke ^a   Azuma, Hiroshi ^a   Ito, Yoshifumi ^a   Isotani, Eiji ^a   Ohno, Kikuo ^a   Hirakawa, Kimiyoshi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Activated protein C; Angiography; Cerebral vasospasm; Endothelium dependent relaxation; Subarachnoid clot; Subarachnoid hemorrhage

Indexed keywords

ACTIVATED PROTEIN C; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN VASOSPASM; CONTROLLED STUDY; DRUG EFFICACY; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE RELAXATION; SUBARACHNOID HEMORRHAGE; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTICOAGULANTS; BASILAR ARTERY; DISEASE MODELS, ANIMAL; MALE; PROTEIN C; RABBITS; SUBARACHNOID HEMORRHAGE; VASOCONSTRICTION; VASOSPASM, INTRACRANIAL;

EID: 0036238566     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200205000-00014     Document Type: Article

References (43)

1. A review of hemoglobin and the pathogenesis of cerebral vasospasm
2. Effect of clot removal on cerebral vasospasm
3. Vasospasm prevention with postoperative intrathecal thrombolytic therapy: A retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone
4. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm
5. Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage
6. Preventive effect of thrombin inhibitor "hirudin" on cerebral vasospasm in canines
7. Cerebral arterial contractions induced by human and bovine thrombin
8. Thrombin activity in CSF after SAH is correlated with the degree of SAH, the persistence of subarachnoid clot, and the development of vasospasm
9. The role of inflammation in experimental cerebral vasospasm
10. Interleukin-6 and development of vasospasm after subarachnoid hemorrhage
11. The protein C anticoagulant pathway
12. Mechanism of protein C-dependent clot lysis: Role of plasminogen activator inhibitor
13. Coagulative and fibrinolytic activation in cerebrospinal fluid and plasma after subarachnoid hemorrhage
14. Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme
15. Activated human protein C prevents thrombin-induced thromboembolism in mice: Evidence that activated protein C reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation
16. Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester
17. Binding of activated protein C to a specific receptor on human mononuclear phagocytes inhibits intracellular calcium signaling and monocyte-dependent proliferative responses
18. Human protein C inhibits selectin-mediated cell adhesion: Role of unique fucosylated oligosaccharide
19. Inhibition of platelet-dependent thrombus formation by human activated protein C in a primate model
20. Characteristic effects of activated human protein C on tissue thromboplastin-induced disseminated intravascular coagulation in rabbits
21. Cell mediated events that control blood coagulation and vascular injury
22. Impaired endothelium-dependent relaxation in rabbit pulmonary artery after subarachnoid hemorrhage
23. The role of superoxide anions in the pathogenesis of cerebral vasospasm
24. Effective improvement of the cerebral vasospasm after subarachnoid hemorrhage with low-dose nitroglycerin
25. Timing and indication of surgery for ruptured intracranial aneurysms with regard to cerebral vasospasm
26. Monoclonal antibodies against ICAM-1 and CD18 attenuate cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits
27. Experimental study of intracisternal administration of tissue-type plasminogen activator followed by cerebrospinal fluid drainage in the ultra-early stage of subarachnoid hemorrhage
28. Experimental basilar artery spasm caused by autologous blood application
29. Enhanced endogenous antioxidant activity and inhibition of cerebral vasospasm in rabbits by pretreatment with a nontoxic endotoxin analog, monophosphoryl lipid A
30. Subarachnoid hemorrhage inhibition of endothelium-derived relaxing factor in rabbit basilar artery
31. Role of endothelium in the human uterine arteries during normal menstrual cycle
32. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
33. Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle
34. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon
35. Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats
36. DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage
37. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
38. Thrombin-induced chemotaxis and aggregation of neutrophils
39. Evidence suggestive of activation of the intrinsic pathway of blood coagulation after injection of factor Xa/phospholipid into rabbits
40. Extrinsic pathway of blood coagulation and thrombin in the cerebrospinal fluid after subarachnoid hemorrhage
41. Intravenous nitroglycerin for the treatment of chronic cerebral vasoconstriction in the primate
42. Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production
43. Species specificity of the fibrinolytic effects of activated protein C